Company intelligence / Profile preview

Line Diet

Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

Line Diet is a South Korean healthcare and wellness company primarily focused on medical weight loss and obesity management. The company operates specialized clinics and provides a range of dietary supplements and personalized weight management programs. Their approach often integrates traditional Korean medicine with modern nutritional science to help patients achieve sustainable weight loss. Line Diet is well-known in the Korean market for its branded weight loss products and clinical services tailored to metabolic health.

Therapeutic areas: EndocrinologyMetabolic Disorders
Modalities: Non-pharmacological therapyNutraceuticals
Industry: Non-Academic Healthcare

Beyond the preview

Go deeper on Line Diet.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Line Diet.

Explore the full profile